Aptalis Pharma Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/11 Q1 2012 – amended

ended 12/31/11 Q1

ended 09/30/11 FY 2011

ended 06/30/11 Q3

ended 03/31/11 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer – amended

Details of business combination or exchange offer

Ownership

No filings in this category.

News Filter

Announces FDA Approval of ULTRESA™ Pancrelipase Delayed Release Capsules and VIOKACE™ Pancrelipase Tablets

Material Definitive Agreement

Change in Certifying Accountant, Financial Statements or Exhibits

Change in Certifying Accountant, Financial Statements or Exhibits

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Notice of effectiveness